240 related articles for article (PubMed ID: 24019180)
1. Immunotherapy for acne vulgaris: current status and future directions.
Simonart T
Am J Clin Dermatol; 2013 Dec; 14(6):429-35. PubMed ID: 24019180
[TBL] [Abstract][Full Text] [Related]
2. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
[TBL] [Abstract][Full Text] [Related]
3. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
Liu PF; Hsieh YD; Lin YC; Two A; Shu CW; Huang CM
Curr Drug Metab; 2015; 16(4):245-54. PubMed ID: 26264195
[TBL] [Abstract][Full Text] [Related]
4. Acne vaccines targeting Propionibacterium acnes.
Kao M; Huang CM
G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
[TBL] [Abstract][Full Text] [Related]
5. Vaccinating against Acne: Benefits and Potential Pitfalls.
Contassot E
J Invest Dermatol; 2018 Nov; 138(11):2304-2306. PubMed ID: 30170784
[TBL] [Abstract][Full Text] [Related]
6. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.
Keshari S; Kumar M; Balasubramaniam A; Chang TW; Tong Y; Huang CM
Expert Rev Vaccines; 2019 May; 18(5):433-437. PubMed ID: 30920859
[TBL] [Abstract][Full Text] [Related]
7. Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne.
Miura Y; Ishige I; Soejima N; Suzuki Y; Uchida K; Kawana S; Eishi Y
J Med Dent Sci; 2010 Mar; 57(1):65-74. PubMed ID: 20437767
[TBL] [Abstract][Full Text] [Related]
8. What is new in the pathophysiology of acne, an overview.
Dréno B
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():8-12. PubMed ID: 28805938
[TBL] [Abstract][Full Text] [Related]
9. Propionibacterium acnes colonization in acne and nonacne.
Leyden JJ; McGinley KJ; Vowels B
Dermatology; 1998; 196(1):55-8. PubMed ID: 9557227
[TBL] [Abstract][Full Text] [Related]
10. What is the role of antimicrobial peptides (AMP) in acne vulgaris?
Harder J; Tsuruta D; Murakami M; Kurokawa I
Exp Dermatol; 2013 Jun; 22(6):386-91. PubMed ID: 23711061
[TBL] [Abstract][Full Text] [Related]
11. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients.
Gloor M; Franke M
Arch Dermatol Res; 1978 Jun; 262(1):125-9. PubMed ID: 150822
[TBL] [Abstract][Full Text] [Related]
12. Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris.
Liu PF; Nakatsuji T; Zhu W; Gallo RL; Huang CM
Vaccine; 2011 Apr; 29(17):3230-8. PubMed ID: 21354482
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of Propionibacterium acnes in acne.
Leyden JJ
Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
[TBL] [Abstract][Full Text] [Related]
14. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris.
Coenye T; Honraet K; Rossel B; Nelis HJ
Infect Disord Drug Targets; 2008 Sep; 8(3):156-9. PubMed ID: 18782032
[TBL] [Abstract][Full Text] [Related]
15. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
[TBL] [Abstract][Full Text] [Related]
16. Is acne vulgaris a genuine inflammatory disease?
Zouboulis CC
Dermatology; 2001; 203(4):277-9. PubMed ID: 11752811
[No Abstract] [Full Text] [Related]
17. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes.
Li ZJ; Choi DK; Sohn KC; Seo MS; Lee HE; Lee Y; Seo YJ; Lee YH; Shi G; Zouboulis CC; Kim CD; Lee JH; Im M
J Invest Dermatol; 2014 Nov; 134(11):2747-2756. PubMed ID: 24820890
[TBL] [Abstract][Full Text] [Related]
18. [On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients. Investigations on juvenile acne patients with predominant comedones and healthy controls (author's transl)].
Gloor M; Lamerz A; Höffler U; Franke M
Dermatol Monatsschr; 1980 Dec; 166(12):798-803. PubMed ID: 6452296
[No Abstract] [Full Text] [Related]
19. Acne: a new model of immune-mediated chronic inflammatory skin disease.
Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
[TBL] [Abstract][Full Text] [Related]
20. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
Whiteside JA; Voss JG
J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
